Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2004 Feb;112(2):170–178. doi: 10.1289/ehp.6690

Developmental effects of chlorpyrifos extend beyond neurotoxicity: critical periods for immediate and delayed-onset effects on cardiac and hepatic cell signaling.

Armando Meyer 1, Frederic J Seidler 1, Theodore A Slotkin 1
PMCID: PMC1241826  PMID: 14754571

Abstract

The fetal and neonatal neurotoxicity of chlorpyrifos (CPF) and related insecticides is a major concern. Developmental effects of CPF involve mechanisms over and above cholinesterase inhibition, notably events in cell signaling that are shared by nonneural targets. In the present study, we evaluated the immediate and long-term effects of CPF exposure of rats during different developmental windows [gestational days (GD) 9-12 or 17-20, postnatal days (PN) 1-4 or 11-14] on the adenylyl cyclase (AC) signaling cascade in the heart and liver. In addition to basal AC activity, we assessed the responses to direct AC stimulants (forskolin, Mn2+); to isoproterenol and glucagon, which activate signaling through specific membrane receptors; and to sodium fluoride, which activates the G-proteins that couple the receptors to AC. Few immediate effects on AC were apparent when CPF doses remained below the threshold for systemic toxicity. Nevertheless, CPF exposures on GD9-12, GD17-20, or PN1-4 elicited sex-selective effects that emerged by adulthood (PN60), whereas later exposure (PN11-14) elicited smaller, nonsignificant effects, indicative of closure of the window of vulnerability. Most of the effects were heterologous, involving signaling elements downstream from the receptors, and thus were shared by multiple inputs; superimposed on this basic pattern, there were also selective alterations in receptor-mediated responses. These results suggest that the developmental toxicity of CPF extends beyond the nervous system, to include cell signaling cascades that are vital to cardiac and hepatic homeostasis. Future work needs to address the potential implications of these effects for cardiovascular and metabolic disorders that may emerge long after the end of CPF exposure.

Full Text

The Full Text of this article is available as a PDF (183.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldridge Justin E., Seidler Frederic J., Meyer Armando, Thillai Indira, Slotkin Theodore A. Serotonergic systems targeted by developmental exposure to chlorpyrifos: effects during different critical periods. Environ Health Perspect. 2003 Nov;111(14):1736–1743. doi: 10.1289/ehp.6489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aldridge Justin E., Seidler Frederic J., Slotkin Theodore A. Developmental exposure to chlorpyrifos elicits sex-selective alterations of serotonergic synaptic function in adulthood: critical periods and regional selectivity for effects on the serotonin transporter, receptor subtypes, and cell signaling. Environ Health Perspect. 2004 Feb;112(2):148–155. doi: 10.1289/ehp.6713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Andersen Helle Raun, Vinggaard Anne Marie, Rasmussen Thomas Hoj, Gjermandsen Irene Marianne, Bonefeld-Jørgensen Eva Cecilie. Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicol Appl Pharmacol. 2002 Feb 15;179(1):1–12. doi: 10.1006/taap.2001.9347. [DOI] [PubMed] [Google Scholar]
  4. André C., Couton D., Gaston J., Erraji L., Renia L., Varlet P., Briand P., Guillet J. G. beta2-adrenergic receptor-selective agonist clenbuterol prevents Fas-induced liver apoptosis and death in mice. Am J Physiol. 1999 Mar;276(3 Pt 1):G647–G654. doi: 10.1152/ajpgi.1999.276.3.G647. [DOI] [PubMed] [Google Scholar]
  5. Asai K., Yang G. P., Geng Y. J., Takagi G., Bishop S., Ishikawa Y., Shannon R. P., Wagner T. E., Vatner D. E., Homcy C. J. Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse. J Clin Invest. 1999 Sep;104(5):551–558. doi: 10.1172/JCI7418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Auman J. T., Seidler F. J., Slotkin T. A. Neonatal chlorpyrifos exposure targets multiple proteins governing the hepatic adenylyl cyclase signaling cascade: implications for neurotoxicity. Brain Res Dev Brain Res. 2000 May 11;121(1):19–27. doi: 10.1016/s0165-3806(00)00021-3. [DOI] [PubMed] [Google Scholar]
  7. Barker D. J. P. The developmental origins of adult disease. Eur J Epidemiol. 2003;18(8):733–736. doi: 10.1023/a:1025388901248. [DOI] [PubMed] [Google Scholar]
  8. Barone S., Jr, Das K. P., Lassiter T. L., White L. D. Vulnerable processes of nervous system development: a review of markers and methods. Neurotoxicology. 2000 Feb-Apr;21(1-2):15–36. [PubMed] [Google Scholar]
  9. Bhat N. R., Shanker G., Pieringer R. A. Cell proliferation in growing cultures of dissociated embryonic mouse brain: macromolecule and ornithine decarboxylase synthesis and regulation by hormones and drugs. J Neurosci Res. 1983;10(2):221–230. doi: 10.1002/jnr.490100210. [DOI] [PubMed] [Google Scholar]
  10. Campbell C. G., Seidler F. J., Slotkin T. A. Chlorpyrifos interferes with cell development in rat brain regions. Brain Res Bull. 1997;43(2):179–189. doi: 10.1016/s0361-9230(96)00436-4. [DOI] [PubMed] [Google Scholar]
  11. Claycomb W. C. Biochemical aspects of cardiac muscle differentiation. Possible control of deoxyribonucleic acid synthesis and cell differentiation by adrenergic innervation and cyclic adenosine 3':5'-monophosphate. J Biol Chem. 1976 Oct 10;251(19):6082–6089. [PubMed] [Google Scholar]
  12. Crumpton T. L., Seidler F. J., Slotkin T. A. Developmental neurotoxicity of chlorpyrifos in vivo and in vitro: effects on nuclear transcription factors involved in cell replication and differentiation. Brain Res. 2000 Feb 28;857(1-2):87–98. doi: 10.1016/s0006-8993(99)02357-4. [DOI] [PubMed] [Google Scholar]
  13. Dam K., Garcia S. J., Seidler F. J., Slotkin T. A. Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways. Brain Res Dev Brain Res. 1999 Aug 5;116(1):9–20. doi: 10.1016/s0165-3806(99)00067-x. [DOI] [PubMed] [Google Scholar]
  14. Dam K., Seidler F. J., Slotkin T. A. Developmental neurotoxicity of chlorpyrifos: delayed targeting of DNA synthesis after repeated administration. Brain Res Dev Brain Res. 1998 Jun 15;108(1-2):39–45. doi: 10.1016/s0165-3806(98)00028-5. [DOI] [PubMed] [Google Scholar]
  15. Das K. P., Barone S., Jr Neuronal differentiation in PC12 cells is inhibited by chlorpyrifos and its metabolites: is acetylcholinesterase inhibition the site of action? Toxicol Appl Pharmacol. 1999 Nov 1;160(3):217–230. doi: 10.1006/taap.1999.8767. [DOI] [PubMed] [Google Scholar]
  16. Dodic M., Peers A., Coghlan J. P., May C. N., Lumbers E., Yu Z., Wintour E. M. Altered cardiovascular haemodynamics and baroreceptor-heart rate reflex in adult sheep after prenatal exposure to dexamethasone. Clin Sci (Lond) 1999 Jul;97(1):103–109. [PubMed] [Google Scholar]
  17. Dodic M., Samuel C., Moritz K., Wintour E. M., Morgan J., Grigg L., Wong J. Impaired cardiac functional reserve and left ventricular hypertrophy in adult sheep after prenatal dexamethasone exposure. Circ Res. 2001 Sep 28;89(7):623–629. doi: 10.1161/hh1901.097086. [DOI] [PubMed] [Google Scholar]
  18. Du X. J., Autelitano D. J., Dilley R. J., Wang B., Dart A. M., Woodcock E. A. beta(2)-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis. Circulation. 2000 Jan 4;101(1):71–77. doi: 10.1161/01.cir.101.1.71. [DOI] [PubMed] [Google Scholar]
  19. Fraeyman N., Van de Velde E., Van Ermen A., Bazan A., Vanderheyden P., Van Emmelo J., Vandekerckhove J. Effect of maturation and aging on beta-adrenergic signal transduction in rat kidney and liver. Biochem Pharmacol. 2000 Dec 15;60(12):1787–1795. doi: 10.1016/s0006-2952(00)00493-7. [DOI] [PubMed] [Google Scholar]
  20. Freissmuth M., Casey P. J., Gilman A. G. G proteins control diverse pathways of transmembrane signaling. FASEB J. 1989 Aug;3(10):2125–2131. [PubMed] [Google Scholar]
  21. Gao M. H., Lai N. C., Roth D. M., Zhou J., Zhu J., Anzai T., Dalton N., Hammond H. K. Adenylylcyclase increases responsiveness to catecholamine stimulation in transgenic mice. Circulation. 1999 Mar 30;99(12):1618–1622. doi: 10.1161/01.cir.99.12.1618. [DOI] [PubMed] [Google Scholar]
  22. Gao M., Ping P., Post S., Insel P. A., Tang R., Hammond H. K. Increased expression of adenylylcyclase type VI proportionately increases beta-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1038–1043. doi: 10.1073/pnas.95.3.1038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gao Zhiyong, Young Robert A., Trucco Matteo M., Greene Scott R., Hewlett Erik L., Matschinsky Franz M., Wolf Bryan A. Protein kinase A translocation and insulin secretion in pancreatic beta-cells: studies with adenylate cyclase toxin from Bordetella pertussis. Biochem J. 2002 Dec 1;368(Pt 2):397–404. doi: 10.1042/BJ20020999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Garcia S. J., Seidler F. J., Crumpton T. L., Slotkin T. A. Does the developmental neurotoxicity of chlorpyrifos involve glial targets? Macromolecule synthesis, adenylyl cyclase signaling, nuclear transcription factors, and formation of reactive oxygen in C6 glioma cells. Brain Res. 2001 Feb 9;891(1-2):54–68. doi: 10.1016/s0006-8993(00)03189-9. [DOI] [PubMed] [Google Scholar]
  25. Garcia Stephanie J., Seidler Frederic J., Qiao Dan, Slotkin Theodore A. Chlorpyrifos targets developing glia: effects on glial fibrillary acidic protein. Brain Res Dev Brain Res. 2002 Feb 28;133(2):151–161. doi: 10.1016/s0165-3806(02)00283-3. [DOI] [PubMed] [Google Scholar]
  26. Garcia Stephanie J., Seidler Frederic J., Slotkin Theodore A. Developmental neurotoxicity elicited by prenatal or postnatal chlorpyrifos exposure: effects on neurospecific proteins indicate changing vulnerabilities. Environ Health Perspect. 2003 Mar;111(3):297–303. doi: 10.1289/ehp.5791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Gilman A. G. The Albert Lasker Medical Awards. G proteins and regulation of adenylyl cyclase. JAMA. 1989 Oct 6;262(13):1819–1825. [PubMed] [Google Scholar]
  28. Goel A., Chauhan D. P., Dhawan D. K. Protective effects of zinc in chlorpyrifos induced hepatotoxicity: a biochemical and trace elemental study. Biol Trace Elem Res. 2000 May;74(2):171–183. doi: 10.1385/BTER:74:2:171. [DOI] [PubMed] [Google Scholar]
  29. Guidotti A., Weiss B., Costa E. Adenosine 3',5'-monophosphate concentrations and isoproterenol-induced synthesis of deoxyribonucleic acid in mouse parotid gland. Mol Pharmacol. 1972 Sep;8(5):521–530. [PubMed] [Google Scholar]
  30. Güven M., Bayram F., Unlühizarci K., Keleştimur F. Endocrine changes in patients with acute organophosphate poisoning. Hum Exp Toxicol. 1999 Oct;18(10):598–601. doi: 10.1191/096032799678839419. [DOI] [PubMed] [Google Scholar]
  31. Huff R. A., Abou-Donia M. B. In vitro effect of chlorpyrifos oxon on muscarinic receptors and adenylate cyclase. Neurotoxicology. 1995 Summer;16(2):281–290. [PubMed] [Google Scholar]
  32. Huff R. A., Abu-Qare A. W., Abou-Donia M. B. Effects of sub-chronic in vivo chlorpyrifos exposure on muscarinic receptors and adenylate cyclase of rat striatum. Arch Toxicol. 2001 Oct;75(8):480–486. doi: 10.1007/s002040100269. [DOI] [PubMed] [Google Scholar]
  33. Huff R. A., Corcoran J. J., Anderson J. K., Abou-Donia M. B. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum. J Pharmacol Exp Ther. 1994 Apr;269(1):329–335. [PubMed] [Google Scholar]
  34. Hultgãrdh-Nilsson A., Querol-Ferrer V., Jonzon B., Krondahl U., Nilsson J. Cyclic AMP, early response gene expression, and DNA synthesis in rat smooth muscle cells. Exp Cell Res. 1994 Sep;214(1):297–302. doi: 10.1006/excr.1994.1261. [DOI] [PubMed] [Google Scholar]
  35. Johnson D. E., Seidler F. J., Slotkin T. A. Early biochemical detection of delayed neurotoxicity resulting from developmental exposure to chloropyrifos. Brain Res Bull. 1998;45(2):143–147. doi: 10.1016/s0361-9230(97)00329-8. [DOI] [PubMed] [Google Scholar]
  36. Kilts Jason D., Akazawa Toshimasa, Richardson Mark D., Kwatra Madan M. Age increases cardiac Galpha(i2) expression, resulting in enhanced coupling to G protein-coupled receptors. J Biol Chem. 2002 Jun 13;277(34):31257–31262. doi: 10.1074/jbc.M203640200. [DOI] [PubMed] [Google Scholar]
  37. Landrigan P. J., Claudio L., Markowitz S. B., Berkowitz G. S., Brenner B. L., Romero H., Wetmur J. G., Matte T. D., Gore A. C., Godbold J. H. Pesticides and inner-city children: exposures, risks, and prevention. Environ Health Perspect. 1999 Jun;107 (Suppl 3):431–437. doi: 10.1289/ehp.99107s3431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Landrigan P. J. Pesticides and polychlorinated biphenyls (PCBs): an analysis of the evidence that they impair children's neurobehavioral development. Mol Genet Metab. 2001 May;73(1):11–17. doi: 10.1006/mgme.2001.3177. [DOI] [PubMed] [Google Scholar]
  39. Levin E. D., Addy N., Nakajima A., Christopher N. C., Seidler F. J., Slotkin T. A. Persistent behavioral consequences of neonatal chlorpyrifos exposure in rats. Brain Res Dev Brain Res. 2001 Sep 23;130(1):83–89. doi: 10.1016/s0165-3806(01)00215-2. [DOI] [PubMed] [Google Scholar]
  40. Levin Edward D., Addy Nii, Baruah Avanti, Elias Alana, Christopher N. Channelle, Seidler Frederic J., Slotkin Theodore A. Prenatal chlorpyrifos exposure in rats causes persistent behavioral alterations. Neurotoxicol Teratol. 2002 Nov-Dec;24(6):733–741. doi: 10.1016/s0892-0362(02)00272-6. [DOI] [PubMed] [Google Scholar]
  41. Limbird L. E., MacMillan S. T. Mn2+-uncoupling of the catecholamine-sensitive adenylate cyclase system of rat reticulocytes. Parallel effects on cholera toxin-catalyzed ADP-ribosylation of the system. Biochim Biophys Acta. 1981 Nov 5;677(3-4):408–416. doi: 10.1016/0304-4165(81)90254-3. [DOI] [PubMed] [Google Scholar]
  42. May M. Disturbing behavior: neurotoxic effects in children. Environ Health Perspect. 2000 Jun;108(6):A262–A267. doi: 10.1289/ehp.108-a262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. McMillian M. K., Schanberg S. M., Kuhn C. M. Ontogeny of rat hepatic adrenoceptors. J Pharmacol Exp Ther. 1983 Oct;227(1):181–186. [PubMed] [Google Scholar]
  44. Meck W. H., Williams C. L. Characterization of the facilitative effects of perinatal choline supplementation on timing and temporal memory. Neuroreport. 1997 Sep 8;8(13):2831–2835. doi: 10.1097/00001756-199709080-00005. [DOI] [PubMed] [Google Scholar]
  45. Meyer Armando, Seidler Frederic J., Cousins Mandy M., Slotkin Theodore A. Developmental neurotoxicity elicited by gestational exposure to chlorpyrifos: when is adenylyl cyclase a target? Environ Health Perspect. 2003 Dec;111(16):1871–1876. doi: 10.1289/ehp.6468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Montoya D. A., White A. M., Williams C. L., Blusztajn J. K., Meck W. H., Swartzwelder H. S. Prenatal choline exposure alters hippocampal responsiveness to cholinergic stimulation in adulthood. Brain Res Dev Brain Res. 2000 Sep 30;123(1):25–32. doi: 10.1016/s0165-3806(00)00075-4. [DOI] [PubMed] [Google Scholar]
  47. Navarro H. A., Kudlacz E. M., Slotkin T. A. Control of adenylate cyclase activity in developing rat heart and liver: effects of prenatal exposure to terbutaline or dexamethasone. Biol Neonate. 1991;60(2):127–136. doi: 10.1159/000243398. [DOI] [PubMed] [Google Scholar]
  48. Nyirenda M. J., Seckl J. R. Intrauterine events and the programming of adulthood disease: the role of fetal glucocorticoid exposure (Review). Int J Mol Med. 1998 Nov;2(5):607–614. doi: 10.3892/ijmm.2.5.607. [DOI] [PubMed] [Google Scholar]
  49. Olivier K., Jr, Liu J., Pope C. Inhibition of forskolin-stimulated cAMP formation in vitro by paraoxon and chlorpyrifos oxon in cortical slices from neonatal, juvenile, and adult rats. J Biochem Mol Toxicol. 2001;15(5):263–269. doi: 10.1002/jbt.10002. [DOI] [PubMed] [Google Scholar]
  50. Phillips David. Endocrine programming and fetal origins of adult disease. Trends Endocrinol Metab. 2002 Nov;13(9):363–363. doi: 10.1016/s1043-2760(02)00696-3. [DOI] [PubMed] [Google Scholar]
  51. Pope C. N., Chakraborti T. K., Chapman M. L., Farrar J. D., Arthun D. Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticides. Toxicology. 1991;68(1):51–61. doi: 10.1016/0300-483x(91)90061-5. [DOI] [PubMed] [Google Scholar]
  52. Pope C. N., Chakraborti T. K. Dose-related inhibition of brain and plasma cholinesterase in neonatal and adult rats following sublethal organophosphate exposures. Toxicology. 1992;73(1):35–43. doi: 10.1016/0300-483x(92)90168-e. [DOI] [PubMed] [Google Scholar]
  53. Pope C. N. Organophosphorus pesticides: do they all have the same mechanism of toxicity? J Toxicol Environ Health B Crit Rev. 1999 Apr-Jun;2(2):161–181. doi: 10.1080/109374099281205. [DOI] [PubMed] [Google Scholar]
  54. Power Chris, Jefferis Barbara J. M. H. Fetal environment and subsequent obesity: a study of maternal smoking. Int J Epidemiol. 2002 Apr;31(2):413–419. [PubMed] [Google Scholar]
  55. Qiao Dan, Seidler Frederic J., Padilla Stephanie, Slotkin Theodore A. Developmental neurotoxicity of chlorpyrifos: what is the vulnerable period? Environ Health Perspect. 2002 Nov;110(11):1097–1103. doi: 10.1289/ehp.021101097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Qiao Dan, Seidler Frederic J., Tate Charlotte A., Cousins Mandy M., Slotkin Theodore A. Fetal chlorpyrifos exposure: adverse effects on brain cell development and cholinergic biomarkers emerge postnatally and continue into adolescence and adulthood. Environ Health Perspect. 2003 Apr;111(4):536–544. doi: 10.1289/ehp.5828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Rodier P. M. Structural--functional relationships in experimentally induced brain damage. Prog Brain Res. 1988;73:335–348. doi: 10.1016/S0079-6123(08)60514-2. [DOI] [PubMed] [Google Scholar]
  58. Schuh Rosemary A., Lein Pamela J., Beckles Rondell A., Jett David A. Noncholinesterase mechanisms of chlorpyrifos neurotoxicity: altered phosphorylation of Ca2+/cAMP response element binding protein in cultured neurons. Toxicol Appl Pharmacol. 2002 Jul 15;182(2):176–185. doi: 10.1006/taap.2002.9445. [DOI] [PubMed] [Google Scholar]
  59. Singh K., Xiao L., Remondino A., Sawyer D. B., Colucci W. S. Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol. 2001 Dec;189(3):257–265. doi: 10.1002/jcp.10024. [DOI] [PubMed] [Google Scholar]
  60. Slotkin T. A. Developmental cholinotoxicants: nicotine and chlorpyrifos. Environ Health Perspect. 1999 Feb;107 (Suppl 1):71–80. doi: 10.1289/ehp.99107s171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Slotkin T. A., McCook E. C., Lappi S. E., Seidler F. J. Altered development of basal and forskolin-stimulated adenylate cyclase activity in brain regions of rats exposed to nicotine prenatally. Brain Res Dev Brain Res. 1992 Aug 21;68(2):233–239. doi: 10.1016/0165-3806(92)90065-5. [DOI] [PubMed] [Google Scholar]
  62. Song X., Seidler F. J., Saleh J. L., Zhang J., Padilla S., Slotkin T. A. Cellular mechanisms for developmental toxicity of chlorpyrifos: targeting the adenylyl cyclase signaling cascade. Toxicol Appl Pharmacol. 1997 Jul;145(1):158–174. doi: 10.1006/taap.1997.8171. [DOI] [PubMed] [Google Scholar]
  63. Stiles G. L. Mechanisms of receptor activation in adenylate cyclase systems. J Cardiovasc Pharmacol. 1989;14 (Suppl 5):S1–S5. [PubMed] [Google Scholar]
  64. Toschke André Michael, Koletzko Berthold, Slikker William, Jr, Hermann Monika, von Kries Rüdiger. Childhood obesity is associated with maternal smoking in pregnancy. Eur J Pediatr. 2002 Jun 28;161(8):445–448. doi: 10.1007/s00431-002-0983-z. [DOI] [PubMed] [Google Scholar]
  65. Vatner D. E., Asai K., Iwase M., Ishikawa Y., Shannon R. P., Homcy C. J., Vatner S. F. Beta-adrenergic receptor-G protein-adenylyl cyclase signal transduction in the failing heart. Am J Cardiol. 1999 Jun 17;83(12A):80H–85H. doi: 10.1016/s0002-9149(99)00266-0. [DOI] [PubMed] [Google Scholar]
  66. Vinggaard A. M., Hnida C., Breinholt V., Larsen J. C. Screening of selected pesticides for inhibition of CYP19 aromatase activity in vitro. Toxicol In Vitro. 2000 Jun;14(3):227–234. doi: 10.1016/s0887-2333(00)00018-7. [DOI] [PubMed] [Google Scholar]
  67. Ward T. R., Mundy W. R. Organophosphorus compounds preferentially affect second messenger systems coupled to M2/M4 receptors in rat frontal cortex. Brain Res Bull. 1996;39(1):49–55. doi: 10.1016/0361-9230(95)02044-6. [DOI] [PubMed] [Google Scholar]
  68. Weiss E. R., Kelleher D. J., Woon C. W., Soparkar S., Osawa S., Heasley L. E., Johnson G. L. Receptor activation of G proteins. FASEB J. 1988 Oct;2(13):2841–2848. doi: 10.1096/fasebj.2.13.3139484. [DOI] [PubMed] [Google Scholar]
  69. Whitney K. D., Seidler F. J., Slotkin T. A. Developmental neurotoxicity of chlorpyrifos: cellular mechanisms. Toxicol Appl Pharmacol. 1995 Sep;134(1):53–62. doi: 10.1006/taap.1995.1168. [DOI] [PubMed] [Google Scholar]
  70. Zeiders J. L., Seidler F. J., Iaccarino G., Koch W. J., Slotkin T. A. Ontogeny of cardiac beta-adrenoceptor desensitization mechanisms: agonist treatment enhances receptor/G-protein transduction rather than eliciting uncoupling. J Mol Cell Cardiol. 1999 Feb;31(2):413–423. doi: 10.1006/jmcc.1998.0875. [DOI] [PubMed] [Google Scholar]
  71. Zeiders J. L., Seidler F. J., Slotkin T. A. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit. J Mol Cell Cardiol. 1997 Feb;29(2):603–615. doi: 10.1006/jmcc.1996.0303. [DOI] [PubMed] [Google Scholar]
  72. Zhang Hengshan, Liu Jing, Pope Carey N. Age-related effects of chlorpyrifos on muscarinic receptor-mediated signaling in rat cortex. Arch Toxicol. 2002 Jan;75(11-12):676–684. doi: 10.1007/s00204-001-0309-3. [DOI] [PubMed] [Google Scholar]
  73. van Wijk R., Wicks W. D., Bevers M. M., van Rijn J. Rapid arrest of DNA synthesis by N 6 ,O 2' -dibutyryl cyclic adenosine 3',5'-monophosphate in cultured hepatoma cells. Cancer Res. 1973 Jun;33(6):1331–1338. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES